Planet Briefing

First published · Last updated

The Impact of Tumor Immune Microenvironment in EGFR-Mutant Non-Small Cell Lung Cancer on the Efficacy of Osimertinib

Journal article studies the impact of the tumor immune microenvironment on the efficacy of osimertinib in EGFR-mutant non-small cell lung cancer. No further methodological, result, location, or participant details are included in the supplied source data.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
6/10
Geographic reach
1/10
Global importance
3/10
Impact magnitude
3/10
Positivity
6/10
Urgency
2/10

Why it matters

The article examines the relationship between tumor immune microenvironment and osimertinib efficacy in EGFR-mutant non-small cell lung cancer.

Sources

Report an issue